Screener
Collegium Pharmaceutical, Inc. COLL Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s total equity?
- Collegium Pharmaceutical, Inc. (COLL) reported total equity of $311.91M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s total equity changed year-over-year?
- Collegium Pharmaceutical, Inc.'s total equity increased by 34.3% year-over-year, from $232.21M to $311.91M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s total equity?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s total equity has grown at a 10.2% compound annual growth rate (CAGR), from $186.03M to $301.68M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Collegium Pharmaceutical, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude